Obalon Therapeutics Inc (OBLN) |
|
3.16 -0.36 (-10.23%)
|
03-03 16:46 |
|
Open: |
3.55 |
Pre. Close: |
3.52 |
|
High:
|
3.58 |
Low:
|
3.08 |
|
Volume:
|
274,768 |
Market Cap:
|
25M |
|
|
|
|
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.735 - 3.753 |
3.753 - 3.771 |
|
Low:
|
3.399 - 3.421 |
3.421 - 3.442 |
|
Close:
|
3.509 - 3.544 |
3.544 - 3.579 |
|
Technical analysis |
as of: 2021-03-03 4:07:34 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.60  One year: 6.83 |
| Support: |
Support1: 3.08 Support2: 2.56 |
| Resistance: |
Resistance1: 4.79 Resistance2: 5.85 |
| Pivot: |
4.11 |
| Moving Average: |
MA(5): 3.48 MA(20): 4.21
MA(100): 2.21  MA(250): 1.39 |
| MACD: |
MACD(12,26): -0.07 Signal(9): 0.15 |
| Stochastic oscillator: |
%K(14,3): 5.40 %D(3): 5.43 |
| RSI: |
RSI(14): 40.23 |
| 52-week: |
High: 10.77 Low: 0.62 Change(%): 139.2 |
| Average Vol(K): |
3-Month: 1380191 10-Days: 63154 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.OBLN has closed above bottom band by 3.8%. Bollinger Bands are 27% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 01 Mar 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations - Yahoo Finance
Mon, 01 Mar 2021
Obalon Therapeutics Inc (OBLN) Is Up 7.58% Before the Open Monday - InvestorsObserver
Mon, 22 Feb 2021
Is Obalon Therapeutics Inc (OBLN) a Stock to Watch After Gaining 1.04% This Week? - InvestorsObserver
Sun, 14 Feb 2021
Lifshitz Law Firm, P.C. Announces Investigation of CHNG, MGLN, OBLN, and OXFD - Yahoo Finance
Wed, 10 Feb 2021
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, CRHM, GLUU, OXFD, OBLN; Shareholders Are Encouraged to Contact the Firm - PRNewswire
Mon, 08 Feb 2021
Obalon Therapeutics Inc (OBLN) Stock: Buy, Hold, or Sell? - InvestorsObserver
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
|
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
-1.860 |
|
EPS Est Next Year
|
-1.650 |
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.049 |
|
Sales Per Share
|
0.297 |
|
EBITDA (p.s.)
|
-1.798 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
10.46 |
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
